Skip to content

Clinical trials

Completed Hyperparathyroidism, Secondary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperparathyroidism, Secondary Status: Completed Country / region: United States Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20052
20064
20075
20082
20096
20104
20112
20123
20136
20142
20151
20161
20172
20181
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen10
OPKO IP Holdings II, Inc.5
Abbott4
Genzyme, a Sanofi Company4
OPKO Health, Inc.3
Deltanoid Pharmaceuticals2
KAI Pharmaceuticals2
Pathalys Pharma2
Columbia University1
Denver Nephrologists, P.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperparathyroidism, Secondary48
Renal Insufficiency, Chronic27
Kidney Failure, Chronic14
Hyperparathyroidism8
Renal Insufficiency8
Hypocalcemia6
Kidney Diseases6
Parathyroid Diseases6
Vitamin D Deficiency6
Arteriosclerosis1

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.